LENCI, EDOARDO
 Distribuzione geografica
Continente #
NA - Nord America 518
EU - Europa 195
AS - Asia 94
SA - Sud America 33
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 1
Totale 867
Nazione #
US - Stati Uniti d'America 518
IT - Italia 64
CN - Cina 35
SG - Singapore 35
SE - Svezia 32
BR - Brasile 31
IE - Irlanda 31
RU - Federazione Russa 29
CI - Costa d'Avorio 17
HK - Hong Kong 15
DE - Germania 9
FI - Finlandia 9
GB - Regno Unito 8
MA - Marocco 7
IN - India 5
UA - Ucraina 3
AT - Austria 2
BE - Belgio 2
CZ - Repubblica Ceca 2
FR - Francia 2
TR - Turchia 2
AR - Argentina 1
AZ - Azerbaigian 1
BO - Bolivia 1
EU - Europa 1
IQ - Iraq 1
LT - Lituania 1
NL - Olanda 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 867
Città #
Chandler 94
Des Moines 93
New York 40
Fairfield 33
Dublin 31
Ashburn 30
Ancona 25
Boardman 20
Singapore 19
Abidjan 17
Wilmington 17
Hong Kong 15
Houston 13
Ann Arbor 11
Seattle 11
Turin 11
Woodbridge 11
Jacksonville 10
Lawrence 10
Princeton 10
San Mateo 8
Moscow 6
Turku 6
Beijing 5
Los Angeles 5
Munich 5
Pune 5
Arnold 4
Cambridge 4
London 4
San Diego 4
São Paulo 4
Washington 4
Cantu 3
Helsinki 3
Brussels 2
Castelraimondo 2
Chicago 2
Fabriano 2
Falconara Marittima 2
Falls Church 2
Jiaxing 2
Olomouc 2
The Dalles 2
Vienna 2
Wuhan 2
Wuxi 2
Amsterdam 1
Aparecida de Goiânia 1
Araucária 1
Atlanta 1
Aversa 1
Baghdad 1
Baku 1
Barra Mansa 1
Belo Horizonte 1
Blumenau 1
Bolton 1
Boqueirão 1
Brasília 1
Campo Grande 1
Campo Verde 1
Canela 1
Capelinha 1
Caruaru 1
Centro 1
Chongqing 1
Concórdia 1
Cotia 1
Denver 1
Duque de Caxias 1
Gaziantep 1
Guangzhou 1
Hurlingham 1
Itapevi 1
Ituiutaba 1
Jaboatão dos Guararapes 1
Jinan 1
Johannesburg 1
Kilburn 1
La Paz 1
Mantova 1
Marrakesh 1
Mauá 1
Milan 1
Minneapolis 1
Morrinhos 1
Niterói 1
Osimo 1
Palhoça 1
Parobé 1
Philadelphia 1
Piedade 1
Prescot 1
Recife 1
Rio de Janeiro 1
Santa Clara 1
Santo Antônio da Platina 1
Shanghai 1
Shaoxing 1
Totale 668
Nome #
Impact of polypharmacy for chronic ailments in colon cancer patients: A review focused on drug repurposing. 120
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: a systematic review and meta-analysis 118
Electrolyte disorders in cancer patients: a systematic review 95
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab 87
Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer 78
Tumor burden as possible biomarker of outcome in advanced NSCLC patients treated with immunotherapy: a single center, retrospective, real-world analysis 74
Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer 72
Old but gold: the role of drug combinations in improving response to immune check-point inhibitors in thoracic malignancies beyond NSCLC 72
The impact of lifestyle interventions in high‐risk early breast cancer patients: A modeling approach from a single institution experience 71
Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type 63
BRCA mutations and gastrointestinal cancers: When to expect the unexpected? 43
Totale 893
Categoria #
all - tutte 5.166
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.166


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 0 0 0 0 0 0 0 0 6
2020/202199 0 6 4 20 18 0 0 6 8 7 17 13
2021/202287 1 8 1 4 1 9 8 2 16 11 7 19
2022/2023330 18 30 15 22 11 117 0 13 51 3 43 7
2023/2024146 23 3 7 5 16 59 1 5 0 2 1 24
2024/2025221 43 17 3 6 8 14 17 15 42 13 36 7
Totale 893